International Patient Summary Implementation Guide
1.0.0 - CI Build

International Patient Summary Implementation Guide, published by Health Level Seven International - Patient Care Work Group. This is not an authorized publication; it is the continuous build for version 1.0.0). This version is based on the current content of https://github.com/HL7/fhir-ips/ and changes regularly. See the Directory of published versions

Table of Contents

..0 Table of Contents
...1 International Patient Summary Implementation Guide
...2 General Principles
...3 Design Conventions and Principles
...4 Known Issues and Future Development
...5 IPS Structure
...6 Profiles defined as part of the IPS Guide
...7 Datatypes defined for this Guide
...8 Extensions
...9 Terminology artifacts defined as part of the IPS Implementation Guide
...10 Examples
...11 Downloads
...12 Copyrights
...13 Artifacts Summary
....13.1 Allergy Intolerance (IPS)
....13.2 DiagnosticReport (IPS)
....13.3 Observation (Pregnancy: status)
....13.4 Observation (Pregnancy: outcome)
....13.5 Device (IPS)
....13.6 Observation (SH: alcohol use)
....13.7 Imaging Study (IPS)
....13.8 Organization (IPS)
....13.9 Device Use Statement (IPS)
....13.10 Medication Statement (IPS)
....13.11 Observation (Pregnancy: EDD)
....13.12 Device (performer, observer)
....13.13 Media observation (Results: laboratory, media)
....13.14 Specimen (IPS)
....13.15 PractitionerRole (IPS)
....13.16 Immunization (IPS)
....13.17 Observation (SH: tobacco use)
....13.18 Practitioner (IPS)
....13.19 Condition (IPS)
....13.20 Medication (IPS)
....13.21 Observation Results (IPS)
....13.22 Observation Results: laboratory (IPS)
....13.23 Procedure (IPS)
....13.24 Composition (IPS)
....13.25 Observation Results: pathology (IPS)
....13.26 Observation Results: radiology (IPS)
....13.27 Patient (IPS)
....13.28 Coding with translations
....13.29 Ratio (IPS)
....13.30 Codeable Concept (IPS)
....13.31 Range (IPS)
....13.32 Quantity (IPS)
....13.33 SimpleQuantity (IPS)
....13.34 Condition abatement date
....13.35 Medical Devices - IPS
....13.36 Results Radiology Observation - IPS
....13.37 Personal Relationship - IPS
....13.38 Pregnancy Expected Delivery Date Method - IPS
....13.39 Absent or Unknown Procedures - IPS
....13.40 Problem Severity - IPS
....13.41 Results Laboratory Observation - IPS
....13.42 CORE Problem List Finding/Situation/Event (GPS) - IPS
....13.43 Target Site - IPS
....13.44 Allergy intolerance substance condition (GPS) - IPS
....13.45 Results Radiology Textual Observations (GPS-DICOM-LOINC) - IPS
....13.46 Results Laboratory Presence/Absence (GPS) - IPS
....13.47 Medications (example) - IPS
....13.48 Absent or Unknown Problems - IPS
....13.49 Results Radiology Measurement Observation (GPS-DICOM) - IPS
....13.50 Current Smoking Status - IPS
....13.51 Problem Type - IPS
....13.52 Results Laboratory ABO+RH Group (GPS) - IPS
....13.53 Procedures - IPS
....13.54 Results Specimen Collection Method (GPS) - IPS
....13.55 Vaccines - IPS
....13.56 Results Coded Values Laboratory (GPS) - IPS
....13.57 Medicine Doseform - IPS
....13.58 Results Specimen Type (GPS) - IPS
....13.59 Vaccine Target Diseases (GPS) - IPS
....13.60 Pregnancies Summary - IPS
....13.61 Healthcare Professional Roles - IPS
....13.62 SNOMED International Global Patient Set (GPS)
....13.63 Absent or Unknown Allergies - IPS
....13.64 Results Coded Values Pathology (GPS) - IPS
....13.65 Absent or Unknown Medication - IPS
....13.66 Results Organism (GPS) - IPS
....13.67 Absent or Unknown Devices - IPS
....13.68 Medicine Active Substances - IPS
....13.69 Pregnancy Status - IPS
....13.70 Vaccine Target Diseases - IPS
....13.71 Vaccines (GPS) - IPS
....13.72 WHO ATC - IPS
....13.73 Results Pathology Observation - IPS
....13.74 Medications (SNOMED CT) - IPS
....13.75 Allergy Reaction (GPS) - IPS
....13.76 Allergy intolerance substance condition - IPS
....13.77 Absent or Unknown Immunization - IPS
....13.78 Medicine Route of Administration - IPS
....13.79 Absent and Unknown Data - IPS
....13.80 Severity Value Set Mappings - LOINC to FHIR
....13.81 Absence of Information Mappings - IPS to SNOMED CT
....13.82 Severity Value Set Mappings - SNOMED CT to FHIR
....13.83 IPS Bundle example
....13.84 Medication : Simvastatin 40 MG Disintegrating Oral Tablet
....13.85 MedicationStatement: on-going Simvastatin treatment
....13.86 Immunization: Vaccin anti diphtérie-coqueluche-tétanos-poliomyélite (Luxembourg)
....13.87 AllergyIntolerance: No known allergies
....13.88 AllergyIntolerance: resolved allergy
....13.89 Condition: Acute myocardial infarction of anterior wall
....13.90 Procedure: Surgical procedure
....13.91 Practitioner example
....13.92 PractitionerRole: simple example
....13.93 Patient: male patient
....13.94 Patient: minimal example
....13.95 Patient: female patient
....13.96 DeviceUseStatement: No known devices in use
....13.97 Device: No known devices in use
....13.98 Device: device observer example
....13.99 Observation: imaging CT Abdomen W contrast IV
....13.100 Observation: imaging CT Abdomen W contrast IV, sub-observations
....13.101 ImagingStudy: referred DICOM study
....13.102 Organization: example
....13.103 Organization: simple example
....13.104 Organization: lab example
....13.105 Observation: pregnancy edd example
....13.106 Observation: pregnancy status example
....13.107 Observation: pregnancy outcome example
....13.108 Observation: SH tobaccouse example
....13.109 Observation: SH alcoholuse example
....13.110 Specimen: example
....13.111 Observation: serum creatinine example
....13.112 Observation: hemoglobin example
....13.113 Observation: estrogen receptor in tissue example
....13.114 DiagnosticReport: hemoglobin example
....13.115 Media: example